Vitiligo is a skin condition that causes patches of skin to lose their color. It happens when the cells that produce skin pigment (melanocytes) die or stop working. This results in white patches on the skin, often around the eyes, mouth, hands, feet, and arms. It's not contagious and can affect people of all ages.
Every report comes from a Lived member, sent anonymously.
Have you tried Opzelura (Ruxolitinib Cream) for Vitiligo?
Vitiligo is a long-term condition in which the skin loses its color in patches. It happens when the immune system attacks melanocytes, the cells that make melanin, the pigment that colors skin and hair. The affected areas look lighter than a person's natural tone, white or sometimes pink, and hair growing in them can turn white. Patches often appear on the face, hands, feet, around the mouth and eyes, and in skin folds, and they can also affect the inside of the mouth or nose. Vitiligo is not contagious, and it does not damage other organs or cause pain. It affects people of every skin tone, though it is most noticeable on darker or tanned skin. Its main effects are visible ones, and for many people those are significant: living with a highly visible skin change can affect confidence, relationships and how others treat them. There are two main types. Nonsegmental vitiligo, by far the most common, produces patches on both sides of the body (both hands or both knees, for example) and tends to spread slowly, with new patches appearing on and off over the years. Segmental vitiligo affects one area or one side of the body, usually starts earlier in life, spreads for about 6 to 12 months and then typically stops.
Vitiligo develops when immune cells mistakenly target the body's own pigment cells. Why this starts is not fully understood, but genes play a large part. About one in five people with vitiligo has a parent, sibling or child with it, and dozens of genes linked to immune function and pigment cells have been identified. Even so, most children of a parent with vitiligo do not develop it, and even identical twins often differ, which suggests other factors are needed to set it off. People with other autoimmune conditions, particularly thyroid disease, and also type 1 diabetes, are more likely to have vitiligo, especially the nonsegmental type. Patches sometimes first appear or spread at sites of skin injury, friction or a bad sunburn, a pattern called the Koebner phenomenon. Emotional or physical stress is often reported before a flare, but that link is less certain. None of these is something a person did wrong, and there is currently no known way to prevent vitiligo.
A dermatologist can usually diagnose vitiligo from the pattern of the patches and a history of when and how they appeared. A Wood's lamp, a handheld ultraviolet light, makes pigment loss glow brightly and shows patches that are hard to see in ordinary light, especially on fair skin. The examination also sorts out the type of vitiligo and whether it is active, meaning new patches have appeared or existing ones have grown recently, because that shapes treatment choices. Other conditions can cause light patches, including a common yeast infection called tinea versicolor, lightening after eczema or another rash heals, and contact with certain industrial chemicals. A scraping or, rarely, a small skin biopsy can help when the picture is unclear. Because vitiligo is linked to other autoimmune diseases, a blood test to check thyroid function is often recommended, and other tests may be added if symptoms point to a related condition.
Treatment is a choice, not a requirement. Some people prefer to leave their skin as it is or to even out their tone with camouflage makeup, self-tanner or skin dye. For those who want color back, treatment can often restore some or much of it and slow the appearance of new patches, but it cannot cure vitiligo. It works slowly, results vary by location (the face usually responds best, while lips, fingertips and toes respond least), and color can fade after treatment stops, so many people use a lower-intensity maintenance routine. Prescription creams and ointments are the usual starting point for limited areas. Corticosteroid creams calm the immune attack but are used for limited periods because long use can thin the skin. Tacrolimus ointment and pimecrolimus cream, nonsteroid medicines that also quiet the immune response, can be used longer and work especially well on the face and neck; a brief burning or itching where they are applied is common. Ruxolitinib cream (Opzelura) is the only medicine approved by the US Food and Drug Administration specifically for vitiligo. It belongs to a class called Janus kinase (JAK) inhibitors, which block immune signals that drive the attack on pigment cells. It is approved for nonsegmental vitiligo in people 12 and older and is applied twice a day to no more than about 10% of the body. In the main trials, about 30% of people regained at least three quarters of the lost color on their face after 24 weeks, compared with roughly 10% using a plain cream, and results kept improving with continued use. The most common side effects are acne and itching where it is applied. Because its label carries the warnings attached to JAK-inhibitor pills, a prescriber will ask about infections and other immune-suppressing medicines before starting it. Light therapy uses controlled doses of ultraviolet B light to stimulate pigment cells, either from a full-body light box for widespread vitiligo or from a targeted laser or lamp for smaller areas. It takes many sessions over months, and it is often combined with creams to speed results. Side effects are usually mild redness, irritation or itch. When vitiligo is spreading quickly, a dermatologist may add a short course of a steroid medicine taken by mouth to slow it down. For vitiligo that has been stable for at least a year and has not responded to other treatment, surgery can move pigment cells from normal skin into a patch, either as small skin grafts or as a transplant of separated cells. It is not suitable for people whose vitiligo is still active or who form raised scars. For the small number of people who have lost most of their color, a cream that removes the remaining pigment can create an even tone; this is permanent and takes months to years. Vitamins and supplements have not been shown to restore color reliably.
Vitiligo usually lasts for life, but its course is hard to predict. Nonsegmental vitiligo often alternates between quiet periods and spells of spreading, while segmental vitiligo usually settles after its first year. A small amount of color sometimes returns on its own, but full natural repigmentation is uncommon. Treatment is a long project measured in months, and color usually returns gradually rather than all at once. Daily life mostly revolves around sun protection and how a person feels about their skin. Depigmented skin has no natural defense against ultraviolet light and burns quickly, so broad-spectrum sunscreen, protective clothing and shade help prevent painful burns, and they also limit tanning of surrounding skin, which makes patches less noticeable. Vitiligo patches do not appear to carry a higher risk of skin cancer, but sun damage elsewhere still does. The emotional side deserves as much attention as the skin. Anxiety, depression and social withdrawal are more common in people with vitiligo, especially teenagers and people with darker skin, where the contrast is greatest. Support groups, counseling and connecting with others who have vitiligo help many people. Periodic thyroid checks are often part of long-term follow-up because of the link with autoimmune thyroid disease.
See a dermatologist when you notice new light or white patches, both to confirm vitiligo and to rule out other causes. An earlier start tends to give treatment a better chance, so it is worth acting while patches are small. Contact your care team if patches are spreading quickly or new ones keep appearing, if a treatment has produced no meaningful color after about six months, or if creams cause persistent irritation, acne or thinning skin. Also raise it if the condition is weighing on your mood, sleep or social life, or if you develop symptoms of thyroid disease such as unexplained tiredness, weight change or feeling unusually cold or hot.
Last reviewed • Oct 2026
Educational content, not medical advice.
i have had vitiligo for ~40 years (it sucked as a kid, but made me who i am today and wouldn't change a thing!) and have been taking xeljanz every night (5mg) to successfully prevent spreading. highly recommend!